B-precursor Acute Lymphoblastic Leukemia

• CLINICAL_TRIALS trial_result · 2026-04-24
  Clinical Trial Update: Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies [Phase 1]

  Phase 1 trial evaluating anti-CD22 CAR T cells in pediatric and young adult patients with recurrent or refractory CD22-expressing B-cell mal…

• CLINICAL_TRIALS trial_result · 2026-04-09
  Clinical Trial Update: Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]

  This clinical trial update reports the completion of a phase 1/2 study evaluating Brexucabtagene autoleucel (KTE-X19) in pediatric and adole…

• CLINICAL_TRIALS trial_result · 2026-01-08
  Clinical Trial Update: Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL) [Phase 1]

  This clinical trial update indicates completion of a Phase 1 study of intravenous blinatumomab in Japanese adults with newly diagnosed Phila…

• CLINICAL_TRIALS research · 2025-12-16
  Clinical Trial Update: Study of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia [Phase 2]

  Phase 2 study update for brexucabtagene autoleucel (KTE-X19) in adult Japanese patients with relapsed/refractory mantle cell lymphoma or rel…

• CLINICAL_TRIALS research · 2024-05-13
  Clinical Trial Update: Expanded Access Protocol - Blinatumomab in Pediatric & Adolescent Subjects With Relapsed/Refractory B-precursor ALL

  Expanded Access Protocol for blinatumomab in pediatric and adolescent patients with relapsed or refractory B-precursor acute lymphoblastic l…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-03-06
  Clinical Trial Update: GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL [Phase 1, Phase 2]

  A clinical trial update reporting safety and pharmacological characteristics of GNR-084 in refractory or relapsed B-precursor acute lymphobl…

• CLINICAL_TRIALS trial_result · 2021-11-29
  Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3) [Phase 1, Phase 2]

  This update reports the Phase 1/2 ZUMA-3 trial results for Brexucabtagene autoleucel (KTE-X19) in adults with relapsed/refractory B-precurso…

• CLINICAL_TRIALS trial_result · 2020-01-10
  Clinical Trial Update: Study of Blinatumomab in Japanese Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

  Phase 1/2 trial updates the use of blinatumomab in Japanese patients with relapsed/refractory B-precursor ALL; results posted in 2020.

• CLINICAL_TRIALS trial_result · 2017-04-21
  Clinical Trial Update: Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL

  This clinical trial update reports on hematological remission rates and survival among Chinese adults with B-precursor acute lymphoblastic l…